RNAM - Avidity Biosciences, Inc.
72.82
0.020 0.027%
Share volume: 16,757,238
Last Updated: 02-26-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.15%
PREVIOUS CLOSE
CHG
CHG%
$72.80
0.02
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-09-2024 | 11-07-2024 | 02-27-2025 | 05-08-2025 | 11-10-2025 | 02-23-2026 | |
| Total revenue | 3.543 M | 2.045 M | 2.336 M | 2.973 M | 1.573 M | 12.475 M | 860.000 K | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 3.543 M | 2.045 M | 2.336 M | 2.973 M | 1.573 M | 12.475 M | 860.000 K | |
| -42.28% | 14.23% | 27.27% | -47.09% | 693.07% | -93.11% | |||
| Operating expenses | 80.730 M | 84.671 M | 100.470 M | 123.962 M | 133.090 M | 201.281 M | 255.338 M | |
| Selling general and admin | 13.898 M | 20.731 M | 23.273 M | 28.338 M | 33.600 M | 46.333 M | 88.742 M | |
| Research and development | 66.832 M | 63.940 M | 77.197 M | 95.624 M | 99.490 M | 154.948 M | 166.596 M | |
| Total expenses | 80.730 M | 84.671 M | 100.470 M | 123.962 M | 133.090 M | 201.281 M | 255.338 M | |
| 4.88% | 18.66% | 23.38% | 7.36% | 51.24% | 26.86% | |||
| Operating income | -77.187 M | -82.626 M | -98.134 M | -120.989 M | -131.517 M | -188.806 M | -254.478 M | |
| Ebit | -77.187 M | -82.742 M | -98.366 M | -120.788 M | -131.952 M | -189.186 M | -254.955 M | |
| Pretax income | -68.855 M | -70.793 M | -80.398 M | -102.256 M | -115.773 M | -174.442 M | -237.101 M | |
| 2.81% | 13.57% | 27.19% | 13.22% | 50.68% | 35.92% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -68.855 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| 100.00% | ||||||||
| Net income | -68.855 M | -70.793 M | -80.398 M | -102.256 M | -115.773 M | -174.442 M | -237.101 M | |
| -2.81% | -13.57% | -27.19% | -13.22% | -50.68% | -35.92% |